EP3003043A2 - Antimikrobielle fugenmasse mit borzusatz - Google Patents
Antimikrobielle fugenmasse mit borzusatzInfo
- Publication number
- EP3003043A2 EP3003043A2 EP14739271.6A EP14739271A EP3003043A2 EP 3003043 A2 EP3003043 A2 EP 3003043A2 EP 14739271 A EP14739271 A EP 14739271A EP 3003043 A2 EP3003043 A2 EP 3003043A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- joint sealant
- spp
- borate
- sealant material
- material according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000565 sealant Substances 0.000 title claims abstract description 31
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 18
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 title description 5
- 229910052796 boron Inorganic materials 0.000 title description 5
- 239000012812 sealant material Substances 0.000 claims abstract description 21
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 13
- 229910021538 borax Inorganic materials 0.000 claims abstract description 12
- 150000001638 boron Chemical class 0.000 claims abstract description 12
- WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 claims abstract description 12
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 claims abstract description 12
- BIKXLKXABVUSMH-UHFFFAOYSA-N trizinc;diborate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]B([O-])[O-].[O-]B([O-])[O-] BIKXLKXABVUSMH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 9
- 241000228143 Penicillium Species 0.000 claims abstract description 7
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000004599 antimicrobial Substances 0.000 claims abstract description 5
- 241000223600 Alternaria Species 0.000 claims abstract description 4
- 241000588724 Escherichia coli Species 0.000 claims abstract description 4
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000228212 Aspergillus Species 0.000 claims abstract description 3
- 241001465180 Botrytis Species 0.000 claims abstract description 3
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims abstract description 3
- 241000223218 Fusarium Species 0.000 claims abstract description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 3
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 7
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 5
- 230000000843 anti-fungal effect Effects 0.000 claims description 4
- 230000001032 anti-candidal effect Effects 0.000 claims description 3
- 229940121375 antifungal agent Drugs 0.000 claims description 3
- 239000004327 boric acid Substances 0.000 claims description 3
- 239000004568 cement Substances 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- -1 alkaline earth metal borates Chemical class 0.000 claims description 2
- NTBYNMBEYCCFPS-UHFFFAOYSA-N azane boric acid Chemical class N.N.N.OB(O)O NTBYNMBEYCCFPS-UHFFFAOYSA-N 0.000 claims description 2
- 239000004567 concrete Substances 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 239000010440 gypsum Substances 0.000 claims description 2
- 229910052602 gypsum Inorganic materials 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000003973 paint Substances 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 238000009417 prefabrication Methods 0.000 claims description 2
- 239000011378 shotcrete Substances 0.000 claims description 2
- 150000004677 hydrates Chemical group 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 14
- 238000011109 contamination Methods 0.000 abstract description 3
- 238000005260 corrosion Methods 0.000 abstract description 3
- 230000007797 corrosion Effects 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000011265 semifinished product Substances 0.000 abstract description 2
- 150000001639 boron compounds Chemical class 0.000 abstract 1
- 244000005700 microbiome Species 0.000 description 15
- 239000000203 mixture Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 238000002768 Kirby-Bauer method Methods 0.000 description 8
- 229960004599 sodium borate Drugs 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 7
- 241000233866 Fungi Species 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- FZQSLXQPHPOTHG-UHFFFAOYSA-N [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 Chemical compound [K+].[K+].O1B([O-])OB2OB([O-])OB1O2 FZQSLXQPHPOTHG-UHFFFAOYSA-N 0.000 description 5
- 238000005299 abrasion Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010039085 Rhinitis allergic Diseases 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 201000010105 allergic rhinitis Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229960002645 boric acid Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000011440 grout Substances 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000012449 sabouraud dextrose agar Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000004383 yellowing Methods 0.000 description 2
- HERHQNVDSHUKAK-UHFFFAOYSA-N 6-methylpyrimidine-2,4-diamine Chemical compound CC1=CC(N)=NC(N)=N1 HERHQNVDSHUKAK-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- BXGHQGSNGLGEEI-UHFFFAOYSA-N B([O-])([O-])[O-].B([O-])(O)O.B([O-])([O-])[O-].B([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2] Chemical compound B([O-])([O-])[O-].B([O-])(O)O.B([O-])([O-])[O-].B([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2] BXGHQGSNGLGEEI-UHFFFAOYSA-N 0.000 description 1
- 208000034309 Bacterial disease carrier Diseases 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 241000985263 Cyphellophora laciniata Species 0.000 description 1
- 241000223682 Exophiala Species 0.000 description 1
- 208000000785 Invasive Pulmonary Aspergillosis Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 102000016397 Methyltransferase Human genes 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- OTRAYOBSWCVTIN-UHFFFAOYSA-N OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N Chemical compound OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N OTRAYOBSWCVTIN-UHFFFAOYSA-N 0.000 description 1
- BKIFLZBXPJKAJF-UHFFFAOYSA-N OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N Chemical compound OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.OB(O)O.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N.N BKIFLZBXPJKAJF-UHFFFAOYSA-N 0.000 description 1
- 241001434386 Paraphoma fimeti Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YLSLKNMMMXLUNK-UHFFFAOYSA-N [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] YLSLKNMMMXLUNK-UHFFFAOYSA-N 0.000 description 1
- MXWVLJGUIUZJSQ-UHFFFAOYSA-N [K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] MXWVLJGUIUZJSQ-UHFFFAOYSA-N 0.000 description 1
- XVDCMYGYCHKSOH-UHFFFAOYSA-N [K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] XVDCMYGYCHKSOH-UHFFFAOYSA-N 0.000 description 1
- MZMIWABCFXURCX-UHFFFAOYSA-N [Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].OB(O)[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].OB(O)[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] MZMIWABCFXURCX-UHFFFAOYSA-N 0.000 description 1
- XLLZUKPXODPNPP-UHFFFAOYSA-N [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] XLLZUKPXODPNPP-UHFFFAOYSA-N 0.000 description 1
- BUWURQPWRDROFU-UHFFFAOYSA-N [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] BUWURQPWRDROFU-UHFFFAOYSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000028004 allergic respiratory disease Diseases 0.000 description 1
- 230000003432 anti-folate effect Effects 0.000 description 1
- 229940127074 antifolate Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- NOXNXVPLDITALF-UHFFFAOYSA-N butoxyboronic acid Chemical compound CCCCOB(O)O NOXNXVPLDITALF-UHFFFAOYSA-N 0.000 description 1
- ILOKQJWLMPPMQU-UHFFFAOYSA-N calcium;oxido(oxo)borane Chemical compound [Ca+2].[O-]B=O.[O-]B=O ILOKQJWLMPPMQU-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- AUTNMGCKBXKHNV-UHFFFAOYSA-P diazanium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [NH4+].[NH4+].O1B([O-])OB2OB([O-])OB1O2 AUTNMGCKBXKHNV-UHFFFAOYSA-P 0.000 description 1
- GTYLWUZKRJYAJZ-UHFFFAOYSA-N dibutoxyborinic acid Chemical compound CCCCOB(O)OCCCC GTYLWUZKRJYAJZ-UHFFFAOYSA-N 0.000 description 1
- MEKUERBZVYOCSL-UHFFFAOYSA-N dicalcium dioxidoboranyloxy(dioxido)borane Chemical compound [Ca+2].[Ca+2].[O-]B([O-])OB([O-])[O-] MEKUERBZVYOCSL-UHFFFAOYSA-N 0.000 description 1
- VLSJPRHEVMZIII-UHFFFAOYSA-N diethoxyborinic acid Chemical compound CCOB(O)OCC VLSJPRHEVMZIII-UHFFFAOYSA-N 0.000 description 1
- PSHMSSXLYVAENJ-UHFFFAOYSA-N dilithium;[oxido(oxoboranyloxy)boranyl]oxy-oxoboranyloxyborinate Chemical compound [Li+].[Li+].O=BOB([O-])OB([O-])OB=O PSHMSSXLYVAENJ-UHFFFAOYSA-N 0.000 description 1
- HQYGGVLSRVLMEE-UHFFFAOYSA-N dimagnesium dioxidoboranyloxy(dioxido)borane Chemical compound [Mg+2].[Mg+2].[O-]B([O-])OB([O-])[O-] HQYGGVLSRVLMEE-UHFFFAOYSA-N 0.000 description 1
- CXVAUNIKYTWEFC-UHFFFAOYSA-N dimethoxyborinic acid Chemical compound COB(O)OC CXVAUNIKYTWEFC-UHFFFAOYSA-N 0.000 description 1
- VBMSSIXNKVFLAJ-UHFFFAOYSA-N dipropoxyborinic acid Chemical compound CCCOB(O)OCCC VBMSSIXNKVFLAJ-UHFFFAOYSA-N 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- KUGSJJNCCNSRMM-UHFFFAOYSA-N ethoxyboronic acid Chemical compound CCOB(O)O KUGSJJNCCNSRMM-UHFFFAOYSA-N 0.000 description 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- KKKYJLNWARAYSD-UHFFFAOYSA-N hexacalcium;tetraborate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] KKKYJLNWARAYSD-UHFFFAOYSA-N 0.000 description 1
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- HZRMTWQRDMYLNW-UHFFFAOYSA-N lithium metaborate Chemical compound [Li+].[O-]B=O HZRMTWQRDMYLNW-UHFFFAOYSA-N 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- LOCZQLKNTOXJDV-UHFFFAOYSA-N magnesium;oxido(oxo)borane Chemical compound [Mg+2].[O-]B=O.[O-]B=O LOCZQLKNTOXJDV-UHFFFAOYSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- UYVXZUTYZGILQG-UHFFFAOYSA-N methoxyboronic acid Chemical compound COB(O)O UYVXZUTYZGILQG-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 244000039328 opportunistic pathogen Species 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- IGLGDSDAIYIUDL-UHFFFAOYSA-N pentadecalithium pentaborate Chemical compound [Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-].[O-]B([O-])[O-] IGLGDSDAIYIUDL-UHFFFAOYSA-N 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- JVUYWILPYBCNNG-UHFFFAOYSA-N potassium;oxido(oxo)borane Chemical compound [K+].[O-]B=O JVUYWILPYBCNNG-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- JMVWCCOXRGFPJZ-UHFFFAOYSA-N propoxyboronic acid Chemical compound CCCOB(O)O JMVWCCOXRGFPJZ-UHFFFAOYSA-N 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000004335 respiratory allergy Diseases 0.000 description 1
- NVIFVTYDZMXWGX-UHFFFAOYSA-N sodium metaborate Chemical compound [Na+].[O-]B=O NVIFVTYDZMXWGX-UHFFFAOYSA-N 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- LGQXXHMEBUOXRP-UHFFFAOYSA-N tributyl borate Chemical compound CCCCOB(OCCCC)OCCCC LGQXXHMEBUOXRP-UHFFFAOYSA-N 0.000 description 1
- ZCLIWYZDWIIUSS-UHFFFAOYSA-N tricalcium boric acid diborate Chemical compound B([O-])([O-])[O-].B(O)(O)O.B(O)(O)O.B([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2] ZCLIWYZDWIIUSS-UHFFFAOYSA-N 0.000 description 1
- VLCLHFYFMCKBRP-UHFFFAOYSA-N tricalcium;diborate Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]B([O-])[O-].[O-]B([O-])[O-] VLCLHFYFMCKBRP-UHFFFAOYSA-N 0.000 description 1
- AJSTXXYNEIHPMD-UHFFFAOYSA-N triethyl borate Chemical compound CCOB(OCC)OCC AJSTXXYNEIHPMD-UHFFFAOYSA-N 0.000 description 1
- RIUWBIIVUYSTCN-UHFFFAOYSA-N trilithium borate Chemical class [Li+].[Li+].[Li+].[O-]B([O-])[O-] RIUWBIIVUYSTCN-UHFFFAOYSA-N 0.000 description 1
- UKUWOJWHPCYQDY-UHFFFAOYSA-N trimagnesium boric acid diborate Chemical compound [Mg+2].[Mg+2].[Mg+2].OB(O)O.OB(O)O.[O-]B([O-])[O-].[O-]B([O-])[O-] UKUWOJWHPCYQDY-UHFFFAOYSA-N 0.000 description 1
- NFMWFGXCDDYTEG-UHFFFAOYSA-N trimagnesium;diborate Chemical class [Mg+2].[Mg+2].[Mg+2].[O-]B([O-])[O-].[O-]B([O-])[O-] NFMWFGXCDDYTEG-UHFFFAOYSA-N 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- LTEHWCSSIHAVOQ-UHFFFAOYSA-N tripropyl borate Chemical compound CCCOB(OCCC)OCCC LTEHWCSSIHAVOQ-UHFFFAOYSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/14—Boron; Compounds thereof
Definitions
- the present invention relates to an antimicrobial joint sealant obtained by adding boron derivatives therein.
- Microorganisms such as molds, yeasts and bacteria can live on all known surfaces. These organisms, which are primary and opportunistic pathogens, lead to clinical diseases dangerous to humans.
- Surface adsorption characteristic of the microorganisms is the main aspect that supports microbial life on surfaces. Microorganisms which adsorb to the surface proliferate by using the moisture in the air together with the inorganic and organic nutrients on the surfaces. Microorganisms, whose quantity has risen above a certain level, even if they are not primary pathogens, may be dangerous for individuals especially in hospital environments in which there are patients with suppressed or weak immune systems. Contaminated surfaces transfer their microbial loads to humans via inhalation, touching or nutrition. Especially contamination of the surfaces in hospitals increases hospital -acquired infection risks and affects mortality rate and hospitalization time (Sawrtz, 1994).
- Bacteria and fungi can be shown as the most important reason for environmental diseases, epidemics, acute and chronic allergic risks not only in hospital environment but also in all of the other living spaces. It is observed that particularly molds and yeasts are isolated from all surfaces mainly toilet, bathroom and kitchen surfaces in previous studies. Hamada and Abe (2010) have reported in their study that they have isolated the fungal species such as Ramicloridium strelitzi e, Cyphellophora laciniata, Phoma fimeti, and Exophiala spp. from the bathroom surfaces even under different conditions. Proliferation of these microorganisms above a certain number increases the risk of infection and acute and chronic allergies. Many studies have shown that being exposed to fungus such as Alternaria spp.
- Joint sealant powder made into a grout by mixing with an adequate amount of water, is used for filling in the spaces between the tiles applied on the wall or floor. Due to the cement it contains, the joint sealant grout dries and holds on to the area on which it is applied and ensures that no space remains between the tiles. Although the surface of the tile is water, oil and dust repellent, since the joint sealant between the tiles does not have this characteristic, all of the wastes accumulate on the surface of the joint sealant. These areas satiated with organic wastes and water become an extremely convenient area for microbial growth. Microorganisms settling on material surfaces, in addition to leading to infections, cause materials to wear out and deteriorate.
- Microorganisms proliferate by using organic and inorganic components on materials in addition to the humidity in the air. During reproduction, they damage the structure of materials in different ways and make them dysfunctional. Thousands of health-threatening microorganisms varying according to temperature and humidity rate have been isolated from all of the surfaces and objects inside the house (Reponen et al., 2001). Microorganisms, which can proliferate at any place where they can access humidity and nutrients, cause abrasion on surfaces with the damaging end products they produce both due to using the organic and inorganic nutrients on the surface that they are growing and as a result of their metabolic activities. Thus, this type of surface abrasions may cause significant financial losses. It was determined that microbial abrasion is higher particularly at regions with high humidity rate.
- boric acid has antibacterial activity on enteric bacteria.
- Antimicrobial agents containing boron were applied on gram negative bacteria (Escherichia coli and Proteus mirabilis) and they were found to be effective.
- boric esters have broad spectrum antibacterial activity. They have discovered in their study that boric esters inhibit DNA methyl transferase in gram negative and positive bacteria.
- Reynold et al. (2007) showed that lipophilic 2,4-diamino-6-methylpyrimidine antifolate compound comprising two different borons has moderate antibacterial activity against the bacteria Mycobacterium avium and Lactobacillus case. In addition to these, it is shown that some boron derivatives have antifungal activities.
- Qin et al. (2007) showed that potassium tetraborate has an inhibitory effect on micelle growth of Penicillium expansium.
- the International patent document no. WO2006084161 discloses antimicrobial granules for use in various surface coating and grouting materials.
- the boron added compositions in the state of the art are antibacterial whereas a study on antimicrobial (antibacterial + antifungal + anticandidal) joint sealant is not encountered.
- An objective of the present invention is to provide an antimicrobial joint sealant containing boron derivatives.
- Another objective of the present invention is to provide a joint sealant material which provides protection against microbial decomposition, corrosion and decay on the products and surfaces obtained by using antimicrobial joint sealant.
- a further objective of the present invention is to provide a long lasting joint sealant which prevents the yellowing and discoloration resulting from microbial growth.
- Table 1 shows the results of the modified disc diffusion test conducted with joint sealant materials containing/not containing Zinc Borate (1/10 w/w).
- Table 2 shows the results of the modified disc diffusion test conducted with joint sealant materials containing/not containing Sodium Borate (1/10 w/w).
- Table 3 shows the results of the modified disc diffusion test conducted with joint sealant materials containing/not containing Potassium Borate (1/10 w/w).
- the boron derivatives used in the experimental studies were sodium borate ((Na 2 O)(B 2 O 3 )5.10H 2 O), zinc borate (2Zn0.3B 2 0 3 .3.5H 2 0) and potassium borate ( ⁇ 2 ⁇ 4 ⁇ 7.4 ⁇ 2 0).
- Modified disc diffusion test was employed in the antimicrobial activity tests.
- At least one of sodium borate ((Na 2 O)(B 2 O 3 ) 5 .10H 2 O), zinc borate (2Zn0.3B 2 0 3 .3.5H 2 0) or potassium borate (K 2 B 4 0 7 .4H 2 0) boron derivatives in mineral form was mixed with a commercially available joint sealant at a ratio of 0,5- 20% (w/w). The homogenous mixtures were subjected to antimicrobial activity tests.
- boric acid alkaline or alkaline earth metal borates
- lithium borates such as lithium tetra borate, lithium metaborate, lithium pentaborate
- sodium borates such as sodium metaborate, sodium hexaborate, sodium tetraborate, sodium octaborate
- potassium borates such as potassium tetraborate, potassium metaborate, potassium hexaborate, potassium octaborate
- calcium borates such as calcium diborate, calcium metaborate, calcium tetraborate, tricalcium tetraborate, pentacalcium tetraborate, calcium hexaborate
- magnesium borates such as magnesium metaborate, magnesium diborate, trimagnesium tetraborate, pentamagnesium tetraborate) or all hydrate forms thereof, ammonium borates (ammonium metaborate,
- Standard NCCLS disc diffusion method (Lalitha and Vellore, 2005) with modifications was used to determine the antimicrobial activity of zinc borate and sodium borate on each microorganism tested.
- the lOOul solution containing 10 8 cfu/ml bacteria, 10 6 cfu/ml yeast and 10 4 spor/ml mold was prepared with new cultures and was inoculated on Nutrient Agar (NA), Sabouraud Dextrose Agar (SDA) and Potato Dextrose Agar (PDA), respectively. 20 ⁇ 1 of sterile water was dropped on the empty discs and it was separately immersed into the joint sealant compositions comprising pulverized zinc borate, sodium borate and potassium borates at a concentration of 0.5-10% (w/w).
- the discs coded with the boron containing joint sealant materials were placed on inoculated petri dishes. Empty discs with 20ul drop of sterile water were used as negative control. Ofloxacin (10 ⁇ g/disc) and nystatin (30 ⁇ g/disc) were used as positive control groups for bacteria and fungi, respectively.
- the joint sealant material containing sodium, potassium and zinc borate, applied at specific ratios, was determined to be effective against all tested microorganisms by the modified disc diffusion method, and the results are given in Table 1, 2, and 3.
- a shows that the applied Sodium-Borate ratio is weight/weight
- b + mark shows that joint sealant formulation produced inhibition zone.
- - mark shows that joint sealant formulation did not produce inhibition zone.
- a shows that the applied Potassium-Borate ratio is weight/weight
- b + mark shows that joint sealant formulation produced inhibition zone.
- - mark shows that joint sealant formulation did not produce inhibition zone.
- Antimicrobial activity of the homogenous mixture (boron- joint sealant) containing/non-containing boron derivatives on microorganisms were determined by the modified disc diffusion test. It was found that the mixture prepared at a ratio of 1/10 (w/w) by all three boron derivatives exhibited antimicrobial effect. It was determined that the joint sealant mixture obtained with sodium, zinc and potassium borates were antibacterial (for bacteria), anticandidal (for yeasts) and antifungal (for fungi).
- Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Botrytis spp., Aspergillus spp., Penicillium spp., Fusarium spp., Alternaria spp., Penicillium spp., and Candida spp. could be controlled by means of the boron derivatives added to the joint sealant materials.
- the surfaces of all kinds of raw materials and semi finished products produced from the joint sealant material of the present invention provide protection against microbial contamination and degradation, corrosion and decay.
- the present invention can be applied to cement, concrete, gypsum, liquid or powder paint, prefabrication materials gunite, glue, adhesive, polish or plaster instead of the joint sealant.
- Antibacterial Agents Effects on Growth and Morphology of Bacteria Under Various Culture Conditions". Antimicrobial Agents and Chemotherapy, 17, 549, 1980.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Inorganic Chemistry (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Sealing Material Composition (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR201306616 | 2013-06-03 | ||
| PCT/TR2014/000145 WO2014196940A2 (en) | 2013-06-03 | 2014-06-03 | Boron added antimicrobial joint sealant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP3003043A2 true EP3003043A2 (de) | 2016-04-13 |
Family
ID=51179129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14739271.6A Ceased EP3003043A2 (de) | 2013-06-03 | 2014-06-03 | Antimikrobielle fugenmasse mit borzusatz |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3003043A2 (de) |
| WO (1) | WO2014196940A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3850029A1 (de) | 2019-08-09 | 2021-07-21 | Safas Saf Plastik Sanayi Ve Ticaret Anonim Sirketi | Bormodifizierter flexibler polyurethanschaum für hygiene und verfahren zur herstellung davon |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223636D0 (en) * | 1992-11-11 | 1992-12-23 | Vispak Ltd | Sealants |
| JP3339772B2 (ja) * | 1995-11-30 | 2002-10-28 | 住友ベークライト株式会社 | エポキシ樹脂組成物 |
| JP2001278863A (ja) * | 2000-01-26 | 2001-10-10 | Yoshitomi Fine Chemicals Ltd | ピリチオン含有組成物の変色防止または改善方法および変色が防止された組成物 |
| US8715540B2 (en) * | 2002-01-16 | 2014-05-06 | MG3 Technologies Inc. | Aqueous and dry duel-action flame and smoke retardant and microbe inhibiting compositions, and related methods |
| US8067321B2 (en) * | 2008-05-21 | 2011-11-29 | Icl Performance Products, Lp | Sodium-potassium hexametaphosphate and potassium metaphosphate with a low insolubles content |
| US20100003345A1 (en) * | 2008-07-02 | 2010-01-07 | Kamlesh Gaglani | Synergistic antimicrobial mixtures |
| US8772334B2 (en) * | 2008-07-02 | 2014-07-08 | Kamlesh Gaglani | Synergistic antimicrobial mixtures |
| CN104204340A (zh) * | 2011-11-16 | 2014-12-10 | 巴克托根生物科技产品工业和贸易公司 | 抗微生物纺织品 |
-
2014
- 2014-06-03 EP EP14739271.6A patent/EP3003043A2/de not_active Ceased
- 2014-06-03 WO PCT/TR2014/000145 patent/WO2014196940A2/en active Application Filing
Non-Patent Citations (1)
| Title |
|---|
| None * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014196940A2 (en) | 2014-12-11 |
| WO2014196940A3 (en) | 2015-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grant et al. | The moisture requirements of moulds isolated from domestic dwellings | |
| Nevalainen et al. | Of microbes and men. | |
| KR101363910B1 (ko) | 상승적 항균 조성물 | |
| US20050196430A1 (en) | Antimicrobial enamel glaze | |
| US20150030532A1 (en) | Antimicrobial material comprising a metal ion charged on synthesized zeolite | |
| KR20190012805A (ko) | 항균 및 방충 효과를 갖는 기능성 도료 조성물 | |
| KR101207843B1 (ko) | 도어손잡이의 항균처리방법 및 그 처리방법에 따른 도어손잡이 | |
| Maxim et al. | Preliminary antifungal investigation of ten biocides against moulds from two different church frescoes | |
| CA3014757A1 (en) | Benzoxaborole-containing coating resistant to cellulose-supportable fungus | |
| Singh et al. | Comparative study on antimicrobial efficiency of AgSiO2, ZnAg, and Ag-Zeolite for the application of fishery plastic container | |
| WO2014196940A2 (en) | Boron added antimicrobial joint sealant | |
| WO2005069785A3 (en) | Method of treating surfaces for self-sterilization and microbial growth resistance | |
| İYİGÜNDOĞDU et al. | Development of durable antimicrobial surfaces containing silver-and zinc-ion-exchanged zeolites | |
| RU2540478C1 (ru) | Композиция для получения антимикробного покрытия | |
| Künniger et al. | Antimicrobial efficacy of silver nanoparticles in transparent wood coatings | |
| JPH08209064A (ja) | 天然木化粧合板用抗菌塗料 | |
| ES2434790T3 (es) | Efecto antimicrobiano de agentes antimicrobianos del tipo de diol cicloalifático en composiciones de revestimiento | |
| KR101554027B1 (ko) | 기능성 도료 조성물 | |
| Aciu et al. | MORTAR DE TENCUIALA CU PROPRIETATI ANTIBACTERIENE SI ANTIFUNGICE/PLASTERING MORTAR WITH ANTIBACTERIAL AND ANTIFUNGAL PROPERTIES | |
| Štovícek et al. | The Response of Soil Microbial Communities to Hydration and Desiccation Cycles in Hot Desert Ecosystems | |
| JP2008081712A (ja) | 光触媒性塗布剤 | |
| CN107298883A (zh) | 一种长效抗菌防霉抗藻涂料及其制备方法 | |
| Ejdys et al. | Fungi of the genus Penicillium in school buildings | |
| JP2018507845A (ja) | 相乗的抗微生物組成物 | |
| Ryparová et al. | The occurrence of mold in construction materials before inbuilt into new building and protection against this type of biodegradation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20151222 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20170113 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
| 18R | Application refused |
Effective date: 20180619 |